1. Introduction
Collagen peptide supplements are widely used for their purported benefits in skin, joint, and musculoskeletal health, but questions remain about their safety and the risk of adverse effects. Across randomized controlled trials, systematic reviews, and toxicity studies, the most commonly reported adverse effects among collagen peptide users are mild gastrointestinal symptoms (such as bloating, diarrhea, nausea, and heartburn) and, rarely, allergic reactions—particularly in individuals with known sensitivities to animal-derived proteins (Lin et al., 2023; Siemiątkowski et al., 2024; Fujimoto et al., 2016; Taylor et al., 2022; Choi et al., 2019). Large-scale meta-analyses and clinical trials consistently report that the incidence of adverse events is not significantly higher in collagen peptide groups compared to placebo, and most side effects are transient and mild (Lin et al., 2023; Park et al., 2025; Siemiątkowski et al., 2024; Demir-Dora et al., 2025; Liang et al., 2024; Kim et al., 2018; Choi et al., 2019). Serious adverse events, such as anaphylaxis, are extremely rare but have been documented, especially in at-risk populations (Fujimoto et al., 2016). Long-term animal studies and genotoxicity assessments have not identified significant chronic toxicity or organ-specific risks at typical supplement doses (Seo et al., 2023; Liang et al., 2011; Seo et al., 2024; Dai et al., 2025). However, isolated reports suggest that excessive intake, contamination (e.g., heavy metals in marine collagen), or use in individuals with pre-existing allergies may increase risk (Wang et al., 2023; Siemiątkowski et al., 2024; Fujimoto et al., 2016). Overall, the attributable risk of adverse effects from collagen peptide supplementation in the general population appears to be low, but caution is warranted for those with known allergies or underlying health conditions (Lin et al., 2023; Siemiątkowski et al., 2024; Fujimoto et al., 2016; Liang et al., 2024; Choi et al., 2019).
Figure 1: Consensus meter visualizing the frequency and significance of adverse effects from collagen peptide supplementation.
2. Methods
A comprehensive search was conducted across over 170 million research papers in Consensus, including databases such as Semantic Scholar and PubMed. The search strategy targeted clinical trials, meta-analyses, toxicity studies, and case reports on collagen peptide adverse effects and attributable risk. In total, 972 papers were identified, 473 were screened, 154 were deemed eligible, and the top 50 most relevant papers were included in this review.
| Identification | Screening | Eligibility | Included |
|---|---|---|---|
| 972 | 473 | 154 | 50 |
Figure 2: Flow diagram of the search and selection process for included studies.
Eight unique search strategies were used, focusing on adverse event reporting, specific side effects (gastrointestinal, allergic, musculoskeletal), and comparative risk with placebo.
3. Results
3.1 Most Commonly Reported Adverse Effects
The most frequently reported adverse effects of collagen peptide supplementation are gastrointestinal symptoms (bloating, diarrhea, nausea, heartburn, belching, and stomach pain) (Lin et al., 2023; Siemiątkowski et al., 2024; Taylor et al., 2022; Choi et al., 2019; Kumar et al., 2015). These effects are generally mild, transient, and do not require discontinuation of supplementation (Lin et al., 2023; Siemiątkowski et al., 2024; Taylor et al., 2022; Choi et al., 2019). In randomized controlled trials, the incidence of these symptoms is similar between collagen peptide and placebo groups (Lin et al., 2023; Park et al., 2025; Siemiątkowski et al., 2024; Demir-Dora et al., 2025; Liang et al., 2024; Taylor et al., 2022; Kim et al., 2018; Choi et al., 2019; Kumar et al., 2015).
3.2 Allergic Reactions and At-Risk Populations
Allergic reactions are rare but can be severe, including documented cases of anaphylaxis, particularly in individuals with pre-existing allergies to fish, bovine, or porcine proteins (Siemiątkowski et al., 2024; Fujimoto et al., 2016; Dai et al., 2025). Case reports highlight the importance of source transparency and caution for atopic individuals (Fujimoto et al., 2016; Siemiątkowski et al., 2024).
3.3 Serious and Long-Term Adverse Events
Long-term animal studies and chronic toxicity assessments have not identified significant organ toxicity, genotoxicity, or increased mortality at typical supplement doses (Seo et al., 2023; Liang et al., 2011; Seo et al., 2024; Dai et al., 2025). No significant changes in laboratory parameters, vital signs, or clinical chemistry have been observed in human trials (Park et al., 2025; Lee et al., 2025; Kim et al., 2018; Choi et al., 2019; Dai et al., 2025).
3.4 Attributable Risk Compared to Placebo
Meta-analyses and large RCTs consistently show no significant increase in the risk of adverse events in collagen peptide groups compared to placebo (odds ratio close to 1, p > 0.05) (Lin et al., 2023; Park et al., 2025; Siemiątkowski et al., 2024; Demir-Dora et al., 2025; Liang et al., 2024; Kim et al., 2018; Choi et al., 2019). The attributable risk of adverse effects is therefore low in the general population, with most events being mild and self-limiting (Lin et al., 2023; Siemiątkowski et al., 2024; Liang et al., 2024; Choi et al., 2019).
Results Timeline
2011
1 paper: (Liang et al., 2011)
2016
3 papers: (De Luca et al., 2016; Inoue, Sugihara and Wang, 2016; Fujimoto et al., 2016)
2019
1 paper: (Zelniker et al., 2019)
2020
2 papers: (Mei et al., 2020; Yeo et al., 2020)
2022
3 papers: (Melgarejo et al., 2022; Schwarz et al., 2022; Li et al., 2022)
2023
4 papers: (Wang et al., 2023; Lin et al., 2023; Seo et al., 2023)
2024
1 paper: (Siemiątkowski et al., 2024)
2025
5 papers: (Zhang et al., 2025; Park et al., 2025; Lee et al., 2025; Xiao and Yang, 2025; Demir-Dora et al., 2025)
Figure 3: Timeline of key studies on collagen peptide adverse effects and safety. Larger markers indicate more citations.
Top Contributors
| Type | Name | Papers |
|---|---|---|
| Author | Heung-Sik Seo | (Seo et al., 2023; Seo et al., 2024) |
| Author | Do-Un Kim | (Park et al., 2025; Kim et al., 2018) |
| Author | Naoki Inoue | (Inoue, Sugihara and Wang, 2016; Kumar et al., 2015) |
| Journal | Frontiers in Nutrition | (Park et al., 2025; Xiao and Yang, 2025; Li et al., 2022) |
| Journal | Nutrients | (Kim et al., 2018; Inacio, Chalupe and Vieira, 2024; Wang et al., 2025) |
| Journal | Journal of the science of food and agriculture | (Inoue, Sugihara and Wang, 2016; Kumar et al., 2015) |
Figure 4: Authors & journals that appeared most frequently in the included papers.
4. Discussion
The current body of evidence indicates that collagen peptide supplementation is generally safe, with a low attributable risk of adverse effects in healthy adults (Lin et al., 2023; Park et al., 2025; Siemiątkowski et al., 2024; Demir-Dora et al., 2025; Liang et al., 2024; Kim et al., 2018; Choi et al., 2019). The most common side effects are mild gastrointestinal symptoms, which are not significantly more frequent than with placebo (Lin et al., 2023; Siemiątkowski et al., 2024; Liang et al., 2024; Taylor et al., 2022; Choi et al., 2019). Rare but serious allergic reactions have been reported, especially in individuals with known sensitivities to animal-derived proteins (Siemiątkowski et al., 2024; Fujimoto et al., 2016; Dai et al., 2025). Long-term and high-dose animal studies, as well as genotoxicity assessments, support the absence of significant chronic toxicity or organ-specific risks (Seo et al., 2023; Liang et al., 2011; Seo et al., 2024; Dai et al., 2025). However, the potential for contamination (e.g., heavy metals in marine collagen) and the lack of standardized reporting in supplement studies highlight the need for ongoing vigilance and high-quality research (Wang et al., 2023; Siemiątkowski et al., 2024; Fujimoto et al., 2016; Burns, Perez-Sanchez and Katta, 2020).
Claims and Evidence Table
| Claim | Evidence Strength | Reasoning | Papers |
|---|---|---|---|
| Collagen peptide supplementation is generally safe in healthy adults | Evidence strength: Strong (9/10) | Supported by multiple RCTs, meta-analyses, and long-term toxicity studies showing no significant risk | (Lin et al., 2023; Park et al., 2025; Siemiątkowski et al., 2024; Demir-Dora et al., 2025; Liang et al., 2024; Kim et al., 2018; Choi et al., 2019; Seo et al., 2023; Liang et al., 2011; Seo et al., 2024; Dai et al., 2025) |
| Mild gastrointestinal symptoms are the most common adverse effects | Evidence strength: Strong (8/10) | Consistently reported in RCTs and reviews, but incidence is similar to placebo and symptoms are transient | (Lin et al., 2023; Siemiątkowski et al., 2024; Taylor et al., 2022; Choi et al., 2019; Kumar et al., 2015) |
| Allergic reactions are rare but can be severe in at-risk individuals | Evidence strength: Moderate (6/10) | Case reports and reviews document anaphylaxis in those with pre-existing allergies | (Siemiątkowski et al., 2024; Fujimoto et al., 2016; Dai et al., 2025) |
| No significant increase in adverse event risk compared to placebo | Evidence strength: Strong (8/10) | Meta-analyses and RCTs show odds ratios near 1, p > 0.05 | (Lin et al., 2023; Park et al., 2025; Siemiątkowski et al., 2024; Demir-Dora et al., 2025; Liang et al., 2024; Kim et al., 2018; Choi et al., 2019) |
| Long-term or high-dose use does not cause chronic toxicity in animals | Evidence strength: Moderate (7/10) | Chronic toxicity and genotoxicity studies in animals show no organ-specific or systemic toxicity | (Seo et al., 2023; Liang et al., 2011; Seo et al., 2024; Dai et al., 2025) |
| Contamination and source quality may pose risks in some products | Evidence strength: Moderate (4/10) | Isolated reports of heavy metal contamination in marine collagen and variable supplement quality | (Wang et al., 2023; Siemiątkowski et al., 2024; Fujimoto et al., 2016; Burns, Perez-Sanchez and Katta, 2020) |
Figure 5: Key claims and support evidence identified in these papers.
5. Conclusion
Collagen peptide supplementation is associated with a low risk of adverse effects, with most events being mild gastrointestinal symptoms and rare allergic reactions. The risk of adverse events is not significantly higher than placebo, and long-term toxicity is not supported by current evidence. However, individuals with known allergies or sensitivities to animal-derived proteins should exercise caution, and the quality and source of supplements remain important considerations.
Research Gaps
| Topic/Outcome | Healthy adults | At-risk populations (allergies) | Chronic disease patients | High-dose/long-term use | Children/Adolescents |
|---|---|---|---|---|---|
| GI side effects | 12 | 2 | 1 | 3 | GAP |
| Allergic reactions | 1 | 4 | GAP | GAP | GAP |
| Chronic toxicity | 3 | GAP | 2 | 5 | GAP |
| Attributable risk | 8 | 1 | 1 | 2 | GAP |
Figure 6: Matrix showing research coverage and gaps by population and outcome.
Open Research Questions
Future research should focus on under-studied populations, long-term safety, and standardized adverse event reporting.
| Question | Why |
|---|---|
| What is the long-term safety profile of collagen peptide supplementation in diverse populations? | Most studies are short-term and in healthy adults; long-term effects and risks in other groups are unclear. |
| How can supplement quality and contamination risks (e.g., heavy metals) be minimized and monitored? | Variability in product quality and contamination may pose risks, especially with marine-derived collagen. |
| What is the true incidence and mechanism of allergic reactions to collagen peptides? | Severe allergic reactions are rare but poorly characterized; better understanding is needed for at-risk groups. |
Figure 7: Open research questions for future studies on collagen peptide safety.
In summary, collagen peptide supplementation is generally safe, with a low attributable risk of adverse effects, but ongoing research and vigilance are needed for specific populations and product quality.
References
Wang, L., Zhang, Y., Zhu, Z., Zheng, F., & Gao, R., 2023. Food-derived collagen peptides: safety, metabolism, and anti-skin-aging effects. Current Opinion in Food Science. https://doi.org/10.1016/j.cofs.2023.101012
Lin, C., Tsai, S., Huang, K., Tsai, P., Chou, H., & Chang, S., 2023. Analgesic efficacy of collagen peptide in knee osteoarthritis: a meta-analysis of randomized controlled trials. Journal of Orthopaedic Surgery and Research, 18. https://doi.org/10.1186/s13018-023-04182-w
Melgarejo, J., Wei, D., Latosinska, A., Vanassche, T., Janssens, S., Mischak, H., Staessen, J., Verhamme, P., & Zhang, Z., 2022. Association of fatal and non-fatal adverse health outcomes with urinary peptides reflecting collagen I turnover. European Heart Journal. https://doi.org/10.1093/eurheartj/ehac544.2301
De Luca, C., Mikhal’chik, E., Suprun, M., Papacharalambous, M., Truhanov, A., & Korkina, L., 2016. Skin Antiageing and Systemic Redox Effects of Supplementation with Marine Collagen Peptides and Plant-Derived Antioxidants: A Single-Blind Case-Control Clinical Study. Oxidative Medicine and Cellular Longevity, 2016. https://doi.org/10.1155/2016/4389410
Zhang, X., Li, K., Lu, N., Takebayashi, T., Zhou, B., Xie, H., Li, Y., Long, X., Qin, X., Zhao, H., & Dong, J., 2025. Structural and functional analysis of a homotrimeric collagen peptide. Frontiers in Bioengineering and Biotechnology, 13. https://doi.org/10.3389/fbioe.2025.1575341
Mei, F., Duan, Z., Chen, M., Lu, J., Zhao, M., Li, L., Shen, X., Xia, G., & Chen, S., 2020. Effect of a high-collagen peptide diet on the gut microbiota and short-chain fatty acid metabolism. Journal of Functional Foods, 75, pp. 104278. https://doi.org/10.1016/j.jff.2020.104278
Yeo, J., Qiu, Y., Jung, G., Zhang, Y., Buehler, M., & Kaplan, D., 2020. Adverse effects of Alport syndrome-related Gly missense mutations on collagen type IV: Insights from molecular simulations and experiments.. Biomaterials, 240, pp. 119857. https://doi.org/10.1016/j.biomaterials.2020.119857
Seo, H., Kim, J., Kim, S., Park, M., Seong, N., Kang, G., Kim, J., Kim, S., Kim, J., & Moon, C., 2023. Toxicity of a 90-day repeated oral dose of a collagen peptide derived from skate (Raja kenojei) skin: a rat model study. Toxicological Research, pp. 1-16. https://doi.org/10.1007/s43188-023-00175-3
Schwarz, D., Lipoldová, M., Reinecke, H., & Sohrabi, Y., 2022. Targeting inflammation with collagen. Clinical and Translational Medicine, 12. https://doi.org/10.1002/ctm2.831
Park, S., Lee, S., Kim, H., Park, H., Kim, D., Kim, S., & Heo, I., 2025. Efficacy and safety of low-molecular-weight collagen peptides in knee osteoarthritis: a randomized, double-blind, placebo-controlled trial. Frontiers in Nutrition, 12. https://doi.org/10.3389/fnut.2025.1644899
Lee, E., Ahn, D., Kim, J., Lee, S., Kim, H., Lee, H., & Shin, J., 2025. Skin Anti-Aging and Moisturizing Effects of Low-Molecular-Weight Collagen Peptide Supplementation in Healthy Adults: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial. Journal of Microbiology and Biotechnology, 35. https://doi.org/10.4014/jmb.2507.07008
Xiao, F., & Yang, J., 2025. Commentary: Efficacy and safety of low-molecular-weight collagen peptides in knee osteoarthritis: a randomized, double-blind, placebo-controlled trial. Frontiers in Nutrition. https://doi.org/10.3389/fnut.2025.1712455
Seo, H., Park, M., Seong, N., Kang, G., Kim, S., Kim, J., Kim, S., Kim, J., & Moon, C., 2023. Assessment of single oral dose toxicity of collagen peptide from skate (Raja kenojei) skin. Journal of Biomedical Translational Research. https://doi.org/10.12729/jbtr.2023.24.3.83
Siemiątkowski, R., Haber, M., Czachor, A., Kula, P., Juśkiewicz, A., Grelewicz, O., Kucy, N., Servaas, E., & Kotula, A., 2024. Comparative Analysis of Collagen Supplementation Forms and Their Effects on Multiple Health Parameters. Journal of Education, Health and Sport. https://doi.org/10.12775/jehs.2024.65.55474
Demir-Dora, D., Tuna, S., Kurtoglu, E., Gursoy, S., Balcı, N., Tezman, S., & Erenmemişoğlu, A., 2025. Evaluation of the Efficacy and Safety of CollaSel PRO® Type I and Type III Hydrolyzed Collagen Peptides in the Treatment of Osteoarthritis: A Double-Blind, Placebo-Controlled, Randomized Clinical Trial. Journal of Clinical Medicine, 14. https://doi.org/10.3390/jcm14113655
Inoue, N., Sugihara, F., & Wang, X., 2016. Ingestion of bioactive collagen hydrolysates enhance facial skin moisture and elasticity and reduce facial ageing signs in a randomised double-blind placebo-controlled clinical study.. Journal of the science of food and agriculture, 96 12, pp. 4077-81. https://doi.org/10.1002/jsfa.7606
Fujimoto, W., Fukuda, M., Yokooji, T., Yamamoto, T., Tanaka, A., & Matsuo, H., 2016. Anaphylaxis provoked by ingestion of hydrolyzed fish collagen probably induced by epicutaneous sensitization.. Allergology international : official journal of the Japanese Society of Allergology, 65 4, pp. 474-476. https://doi.org/10.1016/j.alit.2016.03.012
Zelniker, T., Jarolím, P., Scirica, B., Braunwald, E., Park, J., Das, S., Sabatine, M., & Morrow, D., 2019. Biomarker of Collagen Turnover (C‐Terminal Telopeptide) and Prognosis in Patients With Non‐ST‐Elevation Acute Coronary Syndromes. Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 8. https://doi.org/10.1161/jaha.118.011444
Li, X., Cui, L., Feng, G., Yu, S., Shao, G., He, N., & Li, S., 2022. Collagen peptide promotes DSS-induced colitis by disturbing gut microbiota and regulation of macrophage polarization. Frontiers in Nutrition, 9. https://doi.org/10.3389/fnut.2022.957391
Liang, J., Pei, X., Zhang, Z., Wang, N., Wang, J., & Li, Y., 2011. A Chronic Oral Toxicity Study of Marine Collagen Peptides Preparation from Chum Salmon (Oncorhynchus keta) Skin Using Sprague-Dawley Rat. Marine Drugs, 10, pp. 20 – 34. https://doi.org/10.3390/md10010020
Liang, C., Cheng, H., Lee, Y., Liao, C., & Huang, S., 2024. Efficacy and safety of collagen derivatives for osteoarthritis: a trial sequential meta-analysis.. Osteoarthritis and cartilage. https://doi.org/10.1016/j.joca.2023.12.010
Taylor, G., Leonard, A., Tang, J., Dunn, R., Fraser, W., Virgilio, N., Prawitt, J., Stevenson, E., & Clifford, T., 2022. The effects of collagen peptides on exercise-induced gastrointestinal stress: a randomized, controlled trial. European Journal of Nutrition, 62, pp. 1027 – 1039. https://doi.org/10.1007/s00394-022-03051-2
Seo, H., Kim, J., Park, M., Seong, N., Kang, G., Kim, S., Kim, J., Kim, S., Kim, J., & Moon, C., 2024. Genotoxicity evaluation of collagen peptide derived from skate (Raja kenojei) skin: In vitro and in vivo studies. Molecular & Cellular Toxicology, pp. 1-12. https://doi.org/10.1007/s13273-023-00423-5
Kim, D., Chung, H., Choi, J., Sakai, Y., & Lee, B., 2018. Oral Intake of Low-Molecular-Weight Collagen Peptide Improves Hydration, Elasticity, and Wrinkling in Human Skin: A Randomized, Double-Blind, Placebo-Controlled Study. Nutrients, 10. https://doi.org/10.3390/nu10070826
Choi, F., Sung, C., Juhász, M., & Mesinkovsk, N., 2019. Oral Collagen Supplementation: A Systematic Review of Dermatological Applications. Journal of drugs in dermatology : JDD, 18 1, pp. 9-16.
Inacio, P., Chalupe, F., & Vieira, R., 2024. Effects of Hydrolyzed Collagen as a Dietary Supplement on Fibroblast Activation: A Systematic Review. Nutrients, 16. https://doi.org/10.3390/nu16111543
Wang, Y., Wang, Y., Zhuang, X., Zhang, Y., Fang, B., & Fu, Y., 2025. Unraveling the Osteogenic Activity and Molecular Mechanism of an Antioxidant Collagen Peptide in MC3T3-E1 Cells. Nutrients, 17. https://doi.org/10.3390/nu17050824
Dai, Q., Lemke, S., Lu, Y., Taylor, S., Li, H., Fu, S., Wu, X., Wang, N., Xue, T., & He, X., 2025. Food Safety Evaluation of Recombinant Humanized Type III Collagen Produced by Komagataella phaffii SMD1168‐2COL3. Journal of Applied Toxicology, 45. https://doi.org/10.1002/jat.4741
Kumar, S., Sugihara, F., Suzuki, K., Inoue, N., & Venkateswarathirukumara, S., 2015. A double-blind, placebo-controlled, randomised, clinical study on the effectiveness of collagen peptide on osteoarthritis.. Journal of the science of food and agriculture, 95 4, pp. 702-7. https://doi.org/10.1002/jsfa.6752
Burns, E., Perez-Sanchez, A., & Katta, R., 2020. Risks of Skin, Hair, and Nail Supplements. Dermatology Practical & Conceptual, 10. https://doi.org/10.5826/dpc.1004a89